Coave Therapeutics and ABL link up to develop gene therapy manufacturing processes
Agreement between the two companies includes process development of AAV-based gene therapies
Read Moreby John Pinching | Jun 9, 2022 | News | 0
Agreement between the two companies includes process development of AAV-based gene therapies
Read Moreby Lucy Parsons | Aug 11, 2021 | News | 0
US biotech company says European payers have ‘not yet evolved their approach to gene therapy’
Read Moreby Lucy Parsons | Jul 12, 2021 | News | 0
NICE concluded the cost-effectiveness estimates for Libmeldy are unlikely to be within the range that it would consider an effective use of NHS resources
Read Moreby Lucy Parsons | Jun 30, 2021 | News | 0
Innovation passport designation scheme aims to reduce the time to market for promising treatments
Read Moreby Lucy Parsons | Jun 21, 2021 | News | 0
Children treated with gene therapy prior to symptom presentation achieved motor milestones not seen in the natural history of SMA
Read Moreby Lucy Parsons | Jun 15, 2021 | News | 0
Gene therapy was being evaluated for the treatment of the rare eye disease choroideremia
Read Moreby Lucy Parsons | Jun 14, 2021 | News | 0
CTX001 is being evaluated as a one-time treatment for transfusion dependent beta thalassemia and sickle cell disease
Read Moreby Lucy Parsons | Jun 10, 2021 | News | 0
Consortium will assess multiple process analytical technologies used in the cell and gene therapy industry
Read Moreby Lucy Parsons | May 24, 2021 | News | 0
Collaboration will aim to address challenge of timely and costly AAV-based vector manufacturing
Read Moreby Lucy Parsons | May 19, 2021 | News | 0
The Cell & Gene Collective is aiming to advocate for the adoption of next-generation medicine in the UK
Read Moreby Lucy Parsons | May 17, 2021 | News | 0
Company maintained, however, that the study showed ‘positive trends’ across a number of prespecified secondary endpoints
Read Moreby Lucy Parsons | May 13, 2021 | News | 0
The CIFFREO study is expected to enrol 99 ambulatory male patients aged four to seven years old
Read MorePharmaTimes Media Ltd.
Mansard House
Church Road
Little Bookham
Leatherhead
Surrey KT23 3JG
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
F: +44 (0)20 7240 4479